Herpes simplex serious neurological disease in young children: incidence and long-term outcome
- PMID: 21685219
- PMCID: PMC3256733
- DOI: 10.1136/adc.2010.204677
Herpes simplex serious neurological disease in young children: incidence and long-term outcome
Abstract
Objective: To determine the contribution of herpes simplex virus (HSV) to serious neurological disease.
Setting and patients: A 3-year prospective survey of children aged 2-23 months in Britain and Ireland.
Results: 19 children had HSV central nervous system (CNS) infection; 13 aged 2-11 months had focal neuroimaging abnormalities and 11 long-term neurological sequelae. Of six aged 12-35 months, one had abnormal neuroimaging and three long-term neurological sequelae. 17 of the 19 had serious neurological disease. HSV CNS infection accounted for 23% of serious neurological disease in children aged 2-11 months and 4.5% in older children.
Conclusions: The incidence of HSV-induced serious neurological disease in the UK was estimated at 1 in 64 000/year in younger children and 1 in 230 000 in older children. HSV CNS infection has clinical effects ranging from frank encephalitis to severe illness with fever and convulsions to milder disease lacking encephalopathy.
Conflict of interest statement
References
-
- Elbers JM, Bitnun A, Richardson SE, et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 2007;119:e399–407 - PubMed
-
- De Tiège X, Rozenberg F, Héron B. The spectrum of herpes simplex encephalitis in children. Eur J Paediatr Neurol 2008;12:72–81 - PubMed
-
- Chataway J, Davies NW, Farmer S, et al. Herpes simplex encephalitis: an audit of the use of laboratory diagnostic tests. QJM 2004;97:325–30 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources